Apotex launches generic Emend
Apotex is offering fosaprepitant dimeglumine for injection.
The product is the generic of Merck's Emend. It is an antiemetic (anti-nausea) used together with other medications to prevent nausea and vomiting that may be caused by surgery or cancer chemotherapy.
Fosaprepitant had a market value of approximately $279 million, according to IQVIA.
Fosaprepitant for injection is distributed as 1 vial per carton.
The product is the generic of Merck's Emend. It is an antiemetic (anti-nausea) used together with other medications to prevent nausea and vomiting that may be caused by surgery or cancer chemotherapy.
Fosaprepitant had a market value of approximately $279 million, according to IQVIA.
Fosaprepitant for injection is distributed as 1 vial per carton.